Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3458-3463

  Makovitzki, Arik ^a   Fink, Avner ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; LEUCYLHISTIDYLLEUCYLLEUCYLHISTIDYLHISTIDYLLEUCYLLEUCYLHISTIDYL HISTIDYLLEUCYLLEUCYLHISTIDYLLEUCYLLEUCINE; LEUCYLHISTIDYLLEUCYLLEUCYLHISTIDYLLYSYLLEUCYLLEUCYLLYSYL HISTIDYLLEUCYLLEUCYLLYSYLLEUCYLLEUCINE; LEUCYLLYSYLLEUCYLLEUCYLLYSYLLYSYLLEUCYLLEUCYLLYSYLLYSYLLEUCYLL EUCYLLYSYLLEUCYLLEUCINE; LYSINE; PEPTIDE DERIVATIVE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; COMPARATIVE STUDY; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; MALE; PH; PRIORITY JOURNAL; PROSTATE CANCER; SOLID TUMOR; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CARCINOMA, LEWIS LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HISTIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; LYSINE; MALE; MICE; MICE, NUDE; NIH 3T3 CELLS; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 65949122547     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3021     Document Type: Article

References (52)

1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65. (Pubitemid 20008770)
2. Pan JG, Mak TW. Metabolic targeting as an anticancer strategy: dawn of a new era? Sci STKE 2007; 2007: pl4.
3. Tannock IF, Kotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989; 49: 4373-84. (Pubitemid 19208329)
4. Jahde E, Rajewsky MF, Baumgartl H, pH distributions in transplanted neural tumors and normal tissues of BDIX rats as measured with pH mieroelectrodes. Cancer Res 1982; 42: 1498-504.
5. Martin GR, Jain RK. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res 1994; 54: 5670-4. (Pubitemid 24346265)
6. Newell K, Franchi A, Pouyssegur J, Tannock I. Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proc. Natl. Acad. Sci. U S A 1993; 90: 1127-31. (Pubitemid 23053964)
7. Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 1984; 2: 343-66. (Pubitemid 15166545)
8. Zhao R, Gao F, Hanseorn M, Goldman ID. A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier. Clin. Cancer Res 2004; 10: 718-27. (Pubitemid 38180440)
9. Wang Y, Zhao R, Goldman ID. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Clin. Cancer Res 2004; 10: 6256-64. (Pubitemid 39287534)
10. Park HJ, Lyons JC, Ohtsubo T, Song CW. Acidic environment causes apoptosis by increasing caspase activity. Br J. Cancer 1999; 80: 1892-7. (Pubitemid 29391271)
11. Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM. Translocation of molecules into cells by pH- dependent insertion of a transmembrane helix. Proc. Natl. Acad. Sci. U S A 2006; 103: 6460-5.
12. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett 2005; 5: 325-9.
13. Ko J, Park K, Kim YS. et al. Tumoral acidic extracellular pH targeting of pH-responsive MPEG- poly (β-amino ester) block copolymer micelles for cancer therapy. J. Control Release 2007; 123: 109-15. (Pubitemid 47562136)
14. Lee ES, Na K, Bae YH. Polymeric micelle for tumor pH and folate-mediated targeting, J. Control Release 2003; 91: 103-13. (Pubitemid 37288881)
15. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95. (Pubitemid 34100944)
16. Hancock RE, Sahl HG. Antimicrobial and hostdefense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006; 24: 1551-7.
17. Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 2006; 15: 933-46. (Pubitemid 44177845)
18. Lehmann J, Retz M, Sidhu SS. et al. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Eur Urol 2006; 50: 141-7. (Pubitemid 43850110)
19. Meyer JE, Harder J. Antimicrobial peptides in oral cancer. Curr Pharm Des 2007; 13: 3119-30. (Pubitemid 350130961)
20. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 2008; 1778: 357-75.
21. Papo N, Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol. Life Sci 2005; 62: 784-90. (Pubitemid 40655628)
22. Papo N, Braunstein A, Eshhar Z, Shai Y. Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res 2004; 64: 5779-86. (Pubitemid 39095578)
23. Papo N, Seger D, Makovitzki A. et al. Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res 2006; 66: 5371-8. (Pubitemid 43844963)
24. Patel BJ, Pantuck AJ, Zisman A. et al. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer. J. Urol 2000; 164: 1420-5.
25. Sramkoski RM, Pretlow TG, Giaconia JM. et al. A new human prostate carcinoma cell line, 22Rvl. In Vitro Cell Dev Biol. Anim 1999; 35: 403-9. (Pubitemid 29380004)
26. Allen TM, Cleland LG. Serum-induced leakage of liposome contents. Biochim Biophys Acta 1980; 597: 418-26. (Pubitemid 10066496)
27. Gavish Z, Pinthus JH, Barak V. et al. Growth inhibition of prostate cancer xenografts by halofuginone. Prostate 2002; 51: 73-83. (Pubitemid 34492614)
28. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32. (Pubitemid 27079974)
29. Papo N, Shai Y. New lytic peptides based on the d, L amphipathic helix motif preferentially kill tumor cells compared with normal cells. Biochemistry 2003; 42: 9346-54. (Pubitemid 36959242)
30. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J. 1993; 294: 1-14. (Pubitemid 23251903)
31. Dennison SR, Whittaker M, Harris F, Phoenix DA. Anticancer α-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes. Curr Protein Pept Sci 2006; 7: 487-99.
32. Utsugi T, Schroit AJ, Connor J, Bueana CD, Fidler IJ. Elevated expression of phosphatidyl serine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 1991; 51: 3062-6.
33. Dobr2ynska I, Szachowicz-Petelska B, Sulkowski S, Figaszewski Z. Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol. Cell Biochem 2005; 276: 113-9. (Pubitemid 41236216)
34. Cappelli G, Paladini S, DAgata A. [Tumor markers in the diagnosis of pancreatic cancer], Tumori 1999; 85: S19-21. (Pubitemid 29213967)
35. Burdick MD, Harris A, Reid CJ, Iwamura T, Hollingsworth MA. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J. Biol. Chem 1997: 272: 24198-202. (Pubitemid 27418619)
36. Kichler A, Leborgne C, Marz J, Danos O, Bechinger B. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc. Natl. Acad. Sci. U S A 2003; 100: 1564-8. (Pubitemid 36254487)
37. van Kan EJ, van der Bent A, Demel RA, de Kruijff B. Membrane activity of the peptide antibiotic clavanin and the importance of its glycine residues. Biochemistry 2001; 40: 6398-405. (Pubitemid 32472729)
38. Czajkowsky DM, Iwamoto H, Cover TL, Shao Z. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc. Natl. Acad. Sci. US A 1999; 96: 2001-6. (Pubitemid 29117857)
39. Lai R, Takeuchi H, Lomas LO. et al. A new type of antimicrobial protein with multiple histidines from the hard tick, Ambtyomma hebraeum. FASEB J. 2004; 18: 1447-9.
40. Kacprzyk L, Rydengard V, Morgelin M. et al. Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta 2007; 1768: 2667-80. (Pubitemid 350060862)
41. van Kan EJ, Demel RA, van der Bent A, de Kruijff B. The role of the abundant phenylalanines in the mode of action of the antimicrobial peptide clavanin. Biochim Biophys Acta 2003; 1615: 84-92. (Pubitemid 37013470)
42. van Kan EJ, Demel RA, Breukink E, van der Bent A, de Kruijff B. Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry 2002; 41: 7529-39. (Pubitemid 34627779)
43. Ringstad L, Kacprzyk L, Schmidtchen A, Malmsten M. Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. Biochim Biophys Acta 2007; 1768: 715-27. (Pubitemid 46275597)
44. Lee IH, Cho Y, Lehrer RI. Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun 1997; 65: 2898-903. (Pubitemid 27264123)
45. van Kraaij C, Breukink E, Noordermeer MA. et al. Pore formation by nisin involves translocation of its C-terminal part across the membrane. Biochemistry 1998; 37: 16033-40. (Pubitemid 28536240)
46. Makovitzki A, Shai Y. pH-dependent antifungal lipopeptides and their plausible mode of action. Biochemistry 2005; 44: 9775-84. (Pubitemid 40994371)
47. Vogt TC, Bechinger B. The interactions of histidinecontaining amphipathic helical peptide antibiotics with lipid bilayers. The effects of charges and pH. J. Biol. Chem 1999; 274: 29115-21. (Pubitemid 29477075)
48. Leroux J, Roux E, Le Garrec D, Hong K, Drummond DC. N-isopropylaerylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J. Control Release 2001; 72: 71-84. (Pubitemid 32522345)
49. Kichler A, Mason AJ, Bechinger B. Cationic amphipathic histidine-rich peptides for gene delivery. Biochim Biophys Acta 2006; 1758: 301-7.
50. Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995; 13: 61-92.
51. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002; 62: 6132-40. (Pubitemid 35244462)
52. Ran S, Thorpe PE. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J. Radiat Oncol Biol. Phys 2002; 54: 1479-84. (Pubitemid 35380052)